SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-15-324146
Filing Date
2015-09-21
Accepted
2015-09-21 12:03:02
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B4 d912889d424b4.htm 424B4 2570968
2 GRAPHIC g912889g32b53.jpg GRAPHIC 51094
3 GRAPHIC g912889g52e70.jpg GRAPHIC 117011
4 GRAPHIC g912889g67a59.jpg GRAPHIC 36576
5 GRAPHIC g912889g94d16.jpg GRAPHIC 116569
  Complete submission text file 0001193125-15-324146.txt   3014670
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-205073 | Film No.: 151116890
SIC: 2834 Pharmaceutical Preparations